The Ghent-based bioinformatics company MyNeo has been sold to the publicly listed American mRNA specialist Arcturus Therapeutics. The acquisition price has not yet been disclosed.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Ghent-based bioinformatics company MyNeo has been sold to the publicly listed American mRNA specialist Arcturus Therapeutics. The acquisition price has not yet been disclosed.